Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/13/2024 | $18.00 | Buy | Canaccord Genuity |
3/9/2022 | $24.00 → $24.50 | Buy | DA Davidson |
11/5/2021 | $22.00 → $24.00 | Buy | DA Davidson |
10/15/2021 | $22.00 | Buy | DA Davidson |
LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Ste
LEHI, Utah, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 3% to $114.6 million compared to $111.2 million (up 4% in constant currency).GAAP net income attributable to common shareholders was $4.3 million, or $0.23 per diluted common share, compared to $2.8 million, or $0.15 per diluted common share.Adjusted EBITDA was up 5% to $10.7 million compared to $10.3 million. Management
LEHI, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, will conduct a conference call on Thursday, November 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, November 7, 2024Time: 5:00 p.m. Eastern t
SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)
SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)
SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)
Canaccord Genuity initiated coverage of Nature's Sunshine with a rating of Buy and set a new price target of $18.00
DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.50 from $24.00 previously
DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.00 from $22.00 previously
4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)
3 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)
4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)
10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)
8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)
8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)
Natures Sunshine Products (NASDAQ:NATR) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.17 by 29.41 percent. This is a 47.83 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $110.993 million which missed the analyst consensus estimate of $111.200 million by 0.19 percent. This is a 2.17 percent increase over sales of $108.634 million the same period last year.
LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Ste
LEHI, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Kevin Fuller as Global Chief Marketing Officer, effective September 23, 2024. Fuller, a seasoned marketing executive with over two decades of experience in high-performance organizations, brings in-depth global marketing experience to Nature's Sunshine. His deep understanding of the dietary supplement industry combined with his experience launching new products, building powerful brands, and driving customer growth strategies make Fuller an ideal fit for Nature's Sunshine. "We are ver
Jonathon Lanoy to Serve as Interim CFO LEHI, Utah, Sept. 6, 2022 /PRNewswire/ -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the retirement from the company of its Chief Financial Officer Joseph Baty, effective September 30, 2022. Nature's Sunshine has engaged a leading executive search firm to find its next CFO. Jonathan Lanoy, the company's Corporate Controller and Vice President of Finance, will serve as interim CFO, principal financial offi
LEHI, Utah, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 3% to $114.6 million compared to $111.2 million (up 4% in constant currency).GAAP net income attributable to common shareholders was $4.3 million, or $0.23 per diluted common share, compared to $2.8 million, or $0.15 per diluted common share.Adjusted EBITDA was up 5% to $10.7 million compared to $10.3 million. Management
LEHI, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, will conduct a conference call on Thursday, November 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, November 7, 2024Time: 5:00 p.m. Eastern t
LEHI, Utah, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were down 5% to $110.6 million compared to $116.5 million (down 3% in constant currency).Gross margin decreased 125 basis points to 71.4% compared to 72.6%.GAAP net income attributable to common shareholders was $1.3 million, or $0.07 per diluted common share, compared to $2.4 million, or $0.12 per diluted common share.Adjusted EBITDA down